Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00522509
Status:
UNKNOWN
Last Update Posted:
2007-08-29
First Post:
2007-08-28
Brief Title:
Preoperative Hepatic Arterial Infusion Chemotherapy
Sponsor:
IRCCS San Raffaele
Organization:
IRCCS San Raffaele
Study Overview
Official Title:
Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases
Status:
UNKNOWN
Status Verified Date:
2007-05
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the feasibility and results of liver resection after preoperative hepatic artery infusion HAI chemotherapy with FUDR
Detailed Description:
Between 1995 and 2004 239 patients with isolated colorectal liver metastases received HAI chemotherapy with neoadjuvant intent Fifty of these patients underwent subsequent curative liver resection HAI group
Postoperative morbidity liver function tests and long term outcomes were evaluated Adverse events related to HAI chemotherapy were also evaluated
Postoperative morbidity liver function tests and long term outcomes were evaluated Adverse events related to HAI chemotherapy were also evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None